Data from the RestorAATion-2 clinical trial of WVE-006 (GalNAc-RNA editing), including new data from the 400 mg multidose ...

Q4 2025 earnings call recap: 60% revenue growth, 2026 guidance of $60–$62M, PEDD/TriNav expansion, funding and risks—read now.

Forma Life Sciences, which inherited BioDuro’s California production operations earlier this year, has officially ...

Life Sciences Investors delivered a 40.59% NAV return in 2025, supported by innovation-focused biotechnology. Read the full ...

W hile challenges persist in the short term, there are signs pointing toward long-term growth for life sciences, according to JLL’s 2024 Life Sciences Real Estate Perspective and Cluster Analysis. The ...

Turco’s last day will be March 11. His successor will inherit an agency with big ambitions, and a limited time to prove its worth.

Biosecurity experts have repeatedly raised concerns about the convergence of AI with the life sciences. Agentic AI systems ...

It's the final day to submit your nominees for this year's Fiercest Women in Life Sciences! The nomination form will close at 11:59 p.m. ET on Friday, Sept. 26. Every year, we celebrate women making a ...

Ed Field is President of BioLabs NC. Mr. Field has 20+ years c-level experience in building and selling numerous early-stage and publicly-traded biotechnology companies. He has been responsible for ...

T he U.S. life sciences real estate market posted positive net absorption in the fourth quarter even as robust construction completions raised the sector’s vacancy rate to 19.7%, according CBRE’s new ...

William “Bill” McKeon is the President and Chief Executive Officer of the Texas Medical Center. He is responsible for driving strategic, operational and programmatic initiatives across the Texas ...